2m 2m 2m 2m 2m 2m 2m
TURN THERAPEUTIC (TTRX)
NASDAQ
$10.27+$0.09 (+0.88%)
Price as of Oct 23, 2026 7:30 PM EDT- $309.1MMarket Cap
- 105.66%1-Year Change
- BiotechnologyIndustry
TURN THERAPEUTIC (TTRX)
$10.27+$0.09 (+0.88%)
TTRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.18 | ||
Change | +$0.03 (+0.30%) | ||
Open | $10.05 | ||
High | $10.47 | ||
Low | $9.83 | ||
Previous Close | $10.15 | ||
Volume | 113,120 | ||
30-Day Average Volume | 101,229 | ||
1-Week Change | -12.17% | ||
1-Month Change | -33.42% | ||
1-Year Change | 105.66% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $17.0M | ||
Market Cap | $309.1M | ||
Enterprise Value | $304.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$923,364.00 | ||
EBIT | -$5.6M | ||
EBITDA | -$5.6M | ||
Net Working Capital | $1.7M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -55 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -51 | ||
PEG | 0 | ||
Price/Free Cash Flow | -335 | ||
Price/Operating Cash Flow | -335 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue